Abiopharma

🔍 Karlsson Jutta C (Executive)

Company: Amer Sports, Inc. (AS)

Report Date: 2026-04-15

Detailed Transactions and Holdings:

• Acquired 1,485 shares of Ordinary Shares (Direct)
  Date: 2026-04-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 12,453.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 662 shares of Ordinary Shares at $36.26 per share (Direct)
  Date: 2026-04-16 | Code: S | equity_swap_involved: 0 | shares_owned_after: 11,791.00 | transaction_form_type: 4 | Footnotes: F2, F3
• Sold 1,485 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 1,484.00 | transaction_form_type: 4 | Footnotes: F1, F4, F4

Footnotes:

• F1: Each restricted stock unit represents a contingent right to receive one Ordinary Share of Amer Sports, Inc.
• F2: Shares sold pursuant to a sell to cover transaction to satisfy tax withholding obligations upon the vesting of equity awards. The sales were executed automatically pursuant to a sell to cover arrangement and do not represent a discretionary trade by the Reporting Person.
• F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.08 to $36.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F4: Reflects restricted stock units granted under the Amer Sports, Inc. 2024 Omnibus Incentive Plan (the "2024 Omnibus Plan") on April 15, 2024, which are scheduled to vest in generally equal installments on the second and third anniversaries of the grant date, subject to the terms of the 2024 Omnibus Plan and the applicable award agreement.